A CLINICAL CATHETER FOR CONTINUOUS BLOOD GAS MEASUREMENT BY MASS SPECTROMETRYBRANTIGAN JW; DUNN KL; ALBO D et al.1976; J. APPL. PHYSIOL.; U.S.A.; DA. 1976; VOL. 40; NO 3; PP. 443-446; BIBL. 5 REF.Article

Health care issues of the 1990s : what are our responsibilties as surgeons ?ALBO, D. JR.The American journal of surgery. 1993, Vol 166, Num 6, pp 576-580, issn 0002-9610Conference Paper

SPONTANEOUS HEPATIC RUPTURE IN PREGNANCY.NELSON EW; ARCHIBALD L; ALBO D JR et al.1977; AMER. J. SURG.; U.S.A.; DA. 1977; VOL. 134; NO 6; PP. 817-820; BIBL. 23 REF.Article

PREOPERATIVE SELECTION OF PATIENTS FOR LUMBAR SYMPATHECTOMY BY USE OF THE DOPPLER INDEX.SEEGER JM; LAZARUS HM; ALBO D JR et al.1977; AMER. J. SURG.; U.S.A.; DA. 1977; VOL. 134; NO 6; PP. 749-753; BIBL. 20 REF.Article

Thrombospondin-1 up-regulates tumor cell invasion through the urokinase plasminogen activator receptor in head and neck cancer cellsALBO, D; TUSZYNSKI, G. P.The Journal of surgical research. 2004, Vol 120, Num 1, pp 21-26, issn 0022-4804, 6 p.Article

EMBOLIC AND OCCLUSIVE COMPLICATIONS FROM THROMBOSED FEMOROFEMORAL GRAFTSSEEGER JM; KWAN GATT CS; LAZARUS HM et al.1980; J. CARDIOVASC. SURG.; ISSN 0021-9509; ITA; DA. 1980; VOL. 21; NO 5; PP. 547-551; BIBL. 6 REF.Article

DEVELOPMENT OF SMALL DIAMETER VASCULAR PROSTHESIS.LYMAN DJ; ALBO D JR; JACKSON R et al.1977; TRANS., AMER. SOC. ARTIF. INTERN. ORGANS; U.S.A.; DA. 1977; VOL. 23; PP. 253-261; BIBL. 27 REF.Article

PLETHYSMOGRAPHIC MONITORINGLAZARUS HM; ALBO D JR; ELLERTSON DG et al.1975; ROCKY MOUNTAIN MED. J.; U.S.A.; DA. 1975; VOL. 72; NO 3; PP. 118-120; BIBL. 2REF.Article

COMPLIANCE AS A FACTOR EFFECTING THE PATENCY OF A COPOLYURETHANE VASCULAR GRAFT.LYMAN DJ; FAZZIO FJ; VOORHEES H et al.1978; J. BIOMED. MATER. RES.; USA; DA. 1978; VOL. 12; NO 3; PP. 337-345; BIBL. 11 REF.Article

Revascularization of the limbs with urokinase and TEC catheter endarterectomy for occluded bypass grafts. DiscussionMISRA, H. P; ALBO, D. JR.The American journal of surgery. 1993, Vol 166, Num 6, pp 756-759, issn 0002-9610Conference Paper

POLYURETHANE ELASTOMERS IN SURGERY.LYMAN DJ; SEARE WJ JR; ALBO D JR et al.1977; INTERNATION. J. POLYM. MATER.; G.B.; DA. 1977; VOL. 5; NO 3; PP. 211-229; BIBL. 2 P. 1/2; (SYMP. ELASTOMERS MED.; TORONTO, CAN.; 1974)Conference Paper

The effect of thrombospondin-1 and TGF-β1 on pancreatic cancer cell invasionALBO, D; BERGER, D. H; TUSZYNSKI, G. P et al.The Journal of surgical research. 1998, Vol 76, Num 1, pp 86-90, issn 0022-4804Conference Paper

Tumour cell thrombospondin-1 regulates tumour cell adhesion and invasion through the urokinase plasminogen activator receptorALBO, D; ROTHMAN, V. L; ROBERTS, D. D et al.British journal of cancer. 2000, Vol 83, Num 3, pp 298-306, issn 0007-0920Article

Role of urokinase plasminogen activator receptor in thrombospondin 1-mediated tumor cell invasionALBO, D; BERGER, D. H; ROTHMAN, V. L et al.The Journal of surgical research. 1999, Vol 82, Num 2, pp 331-338, issn 0022-4804Article

The relationship of angiogenesis to biological activity in human squamous cell carcinomas of the head and neckALBO, D; GRANICK, M. S; JHALA, N et al.Annals of plastic surgery. 1994, Vol 32, Num 6, pp 588-594, issn 0148-7043Article

Indium 111-labeled leukocyte scanning for detection of prosthetic vascular graft infectionLAWRENCE, P. F; DRIES, D. J; ALAZRAKI, N et al.Journal of vascular surgery. 1985, Vol 2, Num 1, pp 165-173, issn 0741-5214Conference Paper

Atraumatic hemobilia arising from a cirrhotic liverMERRELL, S. W; GILBERTSON, J. J; ALBO, D. JR et al.Surgery. 1989, Vol 106, Num 1, pp 105-109, issn 0039-6060, 5 p.Article

Transforming growth factor-betal inhibits generation of angiostatin by human pancreatic cancer cells. DiscussionO'MAHONY, C. A; ALBO, D; TUSZYNSKI, G. P et al.Surgery. 1998, Vol 124, Num 2, pp 388-393, issn 0039-6060Conference Paper

Angiostatin generation by human pancreatic cancerO'MAHONY, C. A; SEIDEL, A; ALBO, D et al.The Journal of surgical research. 1998, Vol 77, Num 1, pp 55-58, issn 0022-4804Article

Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cellsARNOLETTI, J. P; ALBO, D; GRANICK, M. S et al.Cancer. 1995, Vol 76, Num 6, pp 998-1005, issn 0008-543XConference Paper

Thrombospondin-1 and its CSVTCG-specific receptor in wound healing and cancerROTH, J. J; ALBO, D; ROTHMAN, V. L et al.Annals of plastic surgery. 1998, Vol 40, Num 5, pp 494-501, issn 0148-7043Conference Paper

Computer-assisted image analysis of tumor sections for a new thrombospondin receptorARNOLETTI, J. P; ALBO, D; NIRAG JHALA et al.The American journal of surgery. 1994, Vol 168, Num 5, pp 433-436, issn 0002-9610Conference Paper

Transformation of intestinal epithelial cells by chronic TGF-β1 treatment results in downregulation of the type II TGF-β receptor and induction of cyclooxygenase-2HONGMIAO SHENG; JINYI SHAO; O'MAHONY, C. A et al.Oncogene (Basingstoke). 1999, Vol 18, Num 4, pp 855-867, issn 0950-9232Article

Rational approach to postoperative transfusion in high-risk patients. DiscussionBAXTER, B. T; BAXTER, B. T et al.MINION, D. J; BAXTER, B. T; BAXTER, B. T et al.The American journal of surgery. 1993, Vol 166, Num 6, pp 720-725, issn 0002-9610Conference Paper

Thrombospondin-1 and transforming growth factor-beta1 promote breast tumor cell invasion through up-regulation of the plasminogen/plasmin system. DiscussionALBO, D; BERGER, D. H; WANG, T. N et al.Surgery. 1997, Vol 122, Num 2, pp 493-500, issn 0039-6060Conference Paper